Table 1.
Study population characteristics
| ICU Study Population (N = 5,390) |
|
|---|---|
| Gender (%) | |
| Male | 46.0 |
| Female | 54.0 |
| Age, mean ± SD (years) | 7.82 ± 6.44 |
| Age groups (%) | |
| Neonates (< 1 month) | 2.9 |
| Infant (1 month–1 year) | 18.3 |
| Child (1–12 years) | 46.6 |
| Adolescent (> 12 years) | 32.3 |
| PIM2 risk of mortality (mean ± SD) | 2.3 ± 8.1 |
| Race/ethnicity (%) | |
| Latino | 57.8 |
| Caucasian | 19.3 |
| African American | 7.6 |
| Asian/Indian/Pacific Islander | 6.5 |
| Other/Mixed/Unspecified | 8.7 |
| Insurance Type (%) | |
| Government | 70.1 |
| Non-Government | 28.2 |
| Other | 1.1 |
| None | 0.6 |
| Admission Type (%) | |
| Unscheduled | 55.4 |
| Scheduled | 44.6 |
| Length of Stay, mean ± SD (days) | |
| Physical | 5.1 ± 8.5 |
| Medical | 5.0 ± 8.5 |
| Mortality (%) | 5.2 |
| Primary Diagnosis (%) | |
| Respiratory | 19.6 |
| Oncologic | 11.6 |
| Cardiovascular | 11.4 |
| Neurologic | 11.2 |
| Orthopedic | 10.9 |
| Injury, Poisoning, and Adverse Events | 10.4 |
| Gastrointestinal | 5.7 |
| Infectious | 4.4 |
| Endocrinologic | 1.0 |
| Other | 13.9 |